Target Price | $15.30 |
Price | $10.08 |
Potential |
51.79%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Consumer Portfolio Services, Inc. 2026 .
The average Consumer Portfolio Services, Inc. target price is $15.30.
This is
51.79%
register free of charge
$15.75
56.25%
register free of charge
$15.15
50.30%
register free of charge
|
|
A rating was issued by 7 analysts: 6 Analysts recommend Consumer Portfolio Services, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Consumer Portfolio Services, Inc. stock has an average upside potential 2026 of
51.79%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 372.51 | 457.76 |
9.56% | 22.89% | |
Net Margin | 5.15% | 5.61% |
61.35% | 8.84% |
3 Analysts have issued a sales forecast Consumer Portfolio Services, Inc. 2025 . The average Consumer Portfolio Services, Inc. sales estimate is
This results in the following potential growth metrics:
3 Consumer Portfolio Services, Inc. Analysts have issued a net profit forecast 2025. The average Consumer Portfolio Services, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.79 | 1.19 |
56.11% | 50.63% | |
P/E | 8.45 | |
EV/Sales | 7.62 |
3 Analysts have issued a Consumer Portfolio Services, Inc. forecast for earnings per share. The average Consumer Portfolio Services, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Consumer Portfolio Services, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.